Cargando…
Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
This study aimed to explore the potential contribution of myofibrils to contractile dysfunction in Ca(2+)-paradox hearts. Isolated rat hearts were perfused with Krebs–Henseleit solution (Control), followed by Ca(2+)-depletion, and then Ca(2+)-repletion after Ca(2+)-depletion (Ca(2+)-paradox) by Lang...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437149/ https://www.ncbi.nlm.nih.gov/pubmed/28213770 http://dx.doi.org/10.1007/s11010-017-2954-8 |
_version_ | 1783237536535019520 |
---|---|
author | Kovács, Árpád Kalász, Judit Pásztor, Enikő T. Tóth, Attila Papp, Zoltán Dhalla, Naranjan S. Barta, Judit |
author_facet | Kovács, Árpád Kalász, Judit Pásztor, Enikő T. Tóth, Attila Papp, Zoltán Dhalla, Naranjan S. Barta, Judit |
author_sort | Kovács, Árpád |
collection | PubMed |
description | This study aimed to explore the potential contribution of myofibrils to contractile dysfunction in Ca(2+)-paradox hearts. Isolated rat hearts were perfused with Krebs–Henseleit solution (Control), followed by Ca(2+)-depletion, and then Ca(2+)-repletion after Ca(2+)-depletion (Ca(2+)-paradox) by Langendorff method. During heart perfusion left ventricular developed pressure (LVDP), end-diastolic pressure (LVEDP), rate of pressure development (+ dP/dt), and pressure decay (-dP/dt) were registered. Control LVDP (127.4 ± 6.1 mmHg) was reduced during Ca(2+)-depletion (9.8 ± 1.3 mmHg) and Ca(2+)-paradox (12.9 ± 1.3 mmHg) with similar decline in +dP/dt and –dP/dt. LVEDP was increased in both Ca(2+)-depletion and Ca(2+)-paradox. Compared to Control, myofibrillar Ca(2+)-stimulated ATPase activity was decreased in the Ca(2+)-depletion group (12.08 ± 0.57 vs. 8.13 ± 0.19 µmol P(i)/mg protein/h), besides unvarying Mg(2+) ATPase activity, while upon Ca(2+)-paradox myofibrillar Ca(2+)-stimulated ATPase activity was decreased (12.08 ± 0.57 vs. 8.40 ± 0.22 µmol P(i)/mg protein/h), but Mg(2+) ATPase activity was increased (3.20 ± 0.25 vs. 7.21 ± 0.36 µmol P(i)/mg protein/h). In force measurements of isolated cardiomyocytes at saturating [Ca(2+)], Ca(2+)-depleted cells had lower rate constant of force redevelopment (k (tr,max), 3.85 ± 0.21) and unchanged active tension, while those in Ca(2+)-paradox produced lower active tension (12.12 ± 3.19 kN/m(2)) and k (tr,max) (3.21 ± 23) than cells of Control group (25.07 ± 3.51 and 4.61 ± 22 kN/m(2), respectively). In biochemical assays, α-myosin heavy chain and cardiac troponin T presented progressive degradation during Ca(2+)-depletion and Ca(2+)-paradox. Our results suggest that contractile impairment in Ca(2+)-paradox partially resides in deranged sarcomeric function and compromised myofibrillar ATPase activity as a result of myofilament protein degradation, such as α-myosin heavy chain and cardiac troponin T. Impaired relaxation seen in Ca(2+)-paradoxical hearts is apparently not related to titin, rather explained by the altered myofibrillar ATPase activity. |
format | Online Article Text |
id | pubmed-5437149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-54371492017-06-06 Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts Kovács, Árpád Kalász, Judit Pásztor, Enikő T. Tóth, Attila Papp, Zoltán Dhalla, Naranjan S. Barta, Judit Mol Cell Biochem Article This study aimed to explore the potential contribution of myofibrils to contractile dysfunction in Ca(2+)-paradox hearts. Isolated rat hearts were perfused with Krebs–Henseleit solution (Control), followed by Ca(2+)-depletion, and then Ca(2+)-repletion after Ca(2+)-depletion (Ca(2+)-paradox) by Langendorff method. During heart perfusion left ventricular developed pressure (LVDP), end-diastolic pressure (LVEDP), rate of pressure development (+ dP/dt), and pressure decay (-dP/dt) were registered. Control LVDP (127.4 ± 6.1 mmHg) was reduced during Ca(2+)-depletion (9.8 ± 1.3 mmHg) and Ca(2+)-paradox (12.9 ± 1.3 mmHg) with similar decline in +dP/dt and –dP/dt. LVEDP was increased in both Ca(2+)-depletion and Ca(2+)-paradox. Compared to Control, myofibrillar Ca(2+)-stimulated ATPase activity was decreased in the Ca(2+)-depletion group (12.08 ± 0.57 vs. 8.13 ± 0.19 µmol P(i)/mg protein/h), besides unvarying Mg(2+) ATPase activity, while upon Ca(2+)-paradox myofibrillar Ca(2+)-stimulated ATPase activity was decreased (12.08 ± 0.57 vs. 8.40 ± 0.22 µmol P(i)/mg protein/h), but Mg(2+) ATPase activity was increased (3.20 ± 0.25 vs. 7.21 ± 0.36 µmol P(i)/mg protein/h). In force measurements of isolated cardiomyocytes at saturating [Ca(2+)], Ca(2+)-depleted cells had lower rate constant of force redevelopment (k (tr,max), 3.85 ± 0.21) and unchanged active tension, while those in Ca(2+)-paradox produced lower active tension (12.12 ± 3.19 kN/m(2)) and k (tr,max) (3.21 ± 23) than cells of Control group (25.07 ± 3.51 and 4.61 ± 22 kN/m(2), respectively). In biochemical assays, α-myosin heavy chain and cardiac troponin T presented progressive degradation during Ca(2+)-depletion and Ca(2+)-paradox. Our results suggest that contractile impairment in Ca(2+)-paradox partially resides in deranged sarcomeric function and compromised myofibrillar ATPase activity as a result of myofilament protein degradation, such as α-myosin heavy chain and cardiac troponin T. Impaired relaxation seen in Ca(2+)-paradoxical hearts is apparently not related to titin, rather explained by the altered myofibrillar ATPase activity. Springer US 2017-02-17 2017 /pmc/articles/PMC5437149/ /pubmed/28213770 http://dx.doi.org/10.1007/s11010-017-2954-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Kovács, Árpád Kalász, Judit Pásztor, Enikő T. Tóth, Attila Papp, Zoltán Dhalla, Naranjan S. Barta, Judit Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts |
title | Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts |
title_full | Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts |
title_fullStr | Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts |
title_full_unstemmed | Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts |
title_short | Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts |
title_sort | myosin heavy chain and cardiac troponin t damage is associated with impaired myofibrillar atpase activity contributing to sarcomeric dysfunction in ca(2+)-paradox rat hearts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437149/ https://www.ncbi.nlm.nih.gov/pubmed/28213770 http://dx.doi.org/10.1007/s11010-017-2954-8 |
work_keys_str_mv | AT kovacsarpad myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts AT kalaszjudit myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts AT pasztorenikot myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts AT tothattila myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts AT pappzoltan myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts AT dhallanaranjans myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts AT bartajudit myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts |